 |
160 Products |  |
813 Diseases | | 160 Products |
|
1618 Trials |  |
78436 News |  |
| «12...875876877878879880881882883884885...910911» |
- | ifosfamide / Generic mfg., paclitaxel / Generic mfg.
Trial completion: Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus (clinicaltrials.gov) - Feb 19, 2014
P3, N=166, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed
- | cyclophosphamide / Generic mfg., busulfan / Generic mfg.
Trial completion: High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=66, Completed, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk, Matulane (procarbazine hydrochloride) / Leadiant Biosci
Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease (clinicaltrials.gov) - Feb 19, 2014
P2, N=5, Completed, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=30, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma (clinicaltrials.gov) - Feb 19, 2014
P2, N=60, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma (clinicaltrials.gov) - Feb 19, 2014
P1, N=16, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | paclitaxel / Generic mfg., doxorubicin hydrochloride / Generic mfg.
Trial completion, Metastases: Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=40, Completed, Sponsor: Georgetown University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion, Metastases: High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=192, Completed, Sponsor: NCIC Clinical Trials Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | dacarbazine / Generic mfg., cisplatin / Generic mfg., vinblastine / Generic mfg.
Trial completion, Metastases: SWOG-E3695: Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma (clinicaltrials.gov) - Feb 19, 2014
P3, N=482, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | dactinomycin / Generic mfg., vincristine / Generic mfg.
Trial completion: Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma (clinicaltrials.gov) - Feb 19, 2014
P3, N=483, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Recruiting --> Completed
- | melphalan / Generic mfg., thiotepa / Generic mfg.
Trial completion: Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission (clinicaltrials.gov) - Feb 19, 2014
P1, N=45, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion: Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=30, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | docetaxel / Generic mfg., epirubicin / Generic mfg.
Trial completion, Metastases: Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=50, Completed, Sponsor: NCIC Clinical Trials Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=13, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=21, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion, Metastases: Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=184, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy in Treating Patients With Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P3, N=116, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion: Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia (clinicaltrials.gov) - Feb 19, 2014
P2, N=53, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | decitabine / Generic mfg.
Trial completion: Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=14, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cyclophosphamide / Generic mfg., busulfan / Generic mfg.
Trial completion: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=24, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | melphalan / Generic mfg.
Trial completion: High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Temple University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cyclophosphamide / Generic mfg.
Trial completion: Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=10, Completed, Sponsor: Temple University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cytarabine / Generic mfg., idarubicin hydrochloride / Generic mfg.
Trial completion: Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome (clinicaltrials.gov) - Feb 19, 2014
P2, N=60, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | thioguanine / Generic mfg.
Trial completion: Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (clinicaltrials.gov) - Feb 19, 2014
P3, N=880, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion, Surgery: Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Radiation Therapy Oncology Group
No longer recruiting --> Completed No longer recruiting --> Completed
- | cyclophosphamide / Generic mfg.
Trial completion: High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia (clinicaltrials.gov) - Feb 19, 2014
P1, N=15, Completed, Sponsor: Fred Hutchinson Cancer Research Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion, IO biomarker: POG-9407: Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 19, 2014
P2, N=221, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | topotecan / Generic mfg., carboplatin / Generic mfg.
Trial completion: Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Mayo Clinic
No longer recruiting --> Completed No longer recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion, Metastases: Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=40, Completed, Sponsor: Yale University
No longer recruiting --> Completed Active, not recruiting --> Completed
- | cyclophosphamide / Generic mfg., paclitaxel / Generic mfg., doxorubicin hydrochloride / Generic mfg.
Trial completion: Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=89, Completed, Sponsor: Yale University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion: Chemotherapy in Treating Patients With Retinoblastoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=50, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia (clinicaltrials.gov) - Feb 19, 2014
P2, N=30, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion: Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=45, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | melphalan / Generic mfg.
Trial completion: High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse (clinicaltrials.gov) - Feb 19, 2014
P2, N=50, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion: SWOG-9442: Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors (clinicaltrials.gov) - Feb 19, 2014
P3, N=270, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed No longer recruiting --> Completed
- | ifosfamide / Generic mfg., cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion: Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=43, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma (clinicaltrials.gov) - Feb 19, 2014
P2, N=40, Completed, Sponsor: Barbara Ann Karmanos Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=46, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion: Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Temple University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Temple University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion, Tumor cell, Metastases: Tumor Cell Vaccine in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Hoag Memorial Hospital Presbyterian
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=170, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion: Safety of Estrogens in Lupus: Birth Control Pills (clinicaltrials.gov) - Feb 19, 2014
P3, N=350, Completed, Sponsor: New York University School of Medicine
Recruiting --> Completed No longer recruiting --> Completed
- ||||||| Repatha (evolocumab) / Amgen, Astellas
Trial completion: GAUSS-2: Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 (clinicaltrials.gov) - Feb 19, 2014
P3, N=307, Completed, Sponsor: Amgen
No longer recruiting --> Completed Active, not recruiting --> Completed
- ||||| Epogen (epoetin alfa) / Amgen
Enrollment closed: An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes (clinicaltrials.gov) - Feb 18, 2014
P3, N=132, Active, not recruiting, Sponsor: Janssen-Cilag International NV
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
Enrollment closed: Surgery in Treating Children With Neuroblastoma (clinicaltrials.gov) - Feb 18, 2014
P3, N=968, Active, not recruiting, Sponsor: Children's Oncology Group
Recruiting --> Active, not recruiting Completed --> Active, not recruiting
- ||||| Aimovig (erenumab-aooe) / Amgen, Novartis
New P2 trial: A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention (clinicaltrials.gov) - Feb 17, 2014
P2, N=490, Not yet recruiting, Sponsor: Amgen
- Stivarga (regorafenib) / Bayer
Enrollment change: Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment (clinicaltrials.gov) - Feb 16, 2014
P1, N=35, Recruiting, Sponsor: Bayer
Completed --> Active, not recruiting N=24 --> 35